Oestrogen and androgen receptors in breast cancer and response to endocrine therapy.
作者信息
Persijn J P, Korsten C B, Engelsman E
出版信息
Br Med J. 1975 Nov 29;4(5995):503. doi: 10.1136/bmj.4.5995.503.
Abstract
摘要
相似文献
1
Oestrogen and androgen receptors in breast cancer and response to endocrine therapy.乳腺癌中的雌激素和雄激素受体以及对内分泌治疗的反应。
Br Med J. 1975 Nov 29;4(5995):503. doi: 10.1136/bmj.4.5995.503.
2
Prediction of breast cancer response to endocrine therapy.乳腺癌对内分泌治疗反应的预测。
Cancer Chemother Rep. 1974 Jul-Aug;58(4):513-9.
3
Prognostic value of estrogen receptor to endocrine ablation in cancer of the breast.雌激素受体对乳腺癌内分泌消融的预后价值。
Surg Gynecol Obstet. 1974 Oct;139(4):525-8.
4
Predicting response to endocrine therapy in human breast cancer: a hypothesis.预测人类乳腺癌内分泌治疗反应：一种假说。
Science. 1975 Aug 29;189(4204):726-7. doi: 10.1126/science.168640.
5
Clinical significance of estrogen receptors in human breast cancer.雌激素受体在人类乳腺癌中的临床意义。
Biomedicine. 1974 Nov;20(6):377-83.
6
[Breast cancer and estrogen receptor: from the standpoint of surgical hormone therapy].[乳腺癌与雌激素受体：从外科激素治疗的角度来看]
Horumon To Rinsho. 1974 Apr;22(4):505-12.
7
Cancer of the breast: forward look in the 1970s. Endocrine therapy-the future.乳腺癌：20世纪70年代的展望。内分泌治疗——未来的方向。
Proc R Soc Med. 1974 Apr;67(4):290-2. doi: 10.1177/003591577406700422.
8
Endocrine therapy of breast cancer.乳腺癌的内分泌治疗
Annu Rev Med. 1975;26:353-63. doi: 10.1146/annurev.me.26.020175.002033.
9
[Proceedings: Estrogen receptors in mamma carcinomas and course following endocrine therapy].[会议论文：乳腺癌中的雌激素受体及内分泌治疗后的病程]
Arch Gynakol. 1973 Sep 28;214(1):293-4. doi: 10.1007/BF00671147.
10
[Hormone dependence and the basis of hormone therapy in breast cancer].[激素依赖性与乳腺癌激素治疗的基础]
J Gynecol Obstet Biol Reprod (Paris). 1978 Mar;7(2):183-99.
引用本文的文献
1
The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer.激素疗法治疗三阴性乳腺癌的潜力
Cancers (Basel). 2023 Sep 24;15(19):4702. doi: 10.3390/cancers15194702.
2
Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.雄激素受体（AR）、E-钙黏蛋白和Ki-67作为三阴性乳腺癌（TNBC）患者新出现的靶点和新型预后标志物
PLoS One. 2015 Jun 3;10(6):e0128368. doi: 10.1371/journal.pone.0128368. eCollection 2015.
3
Androgen receptor expression and breast cancer survival in postmenopausal women.雄激素受体表达与绝经后女性乳腺癌生存
Clin Cancer Res. 2011 Apr 1;17(7):1867-74. doi: 10.1158/1078-0432.CCR-10-2021. Epub 2011 Feb 15.
4
Bilateral ovariectomy in premenopausal patients with advanced breast cancer, after the evaluation of estrogen receptors and urinary androgen excretion.在评估雌激素受体和尿雄激素排泄后，对绝经前晚期乳腺癌患者进行双侧卵巢切除术。
Breast Cancer Res Treat. 1982;2(1):101-4. doi: 10.1007/BF01805722.
5
Androgen receptors, serum androgen levels and survival of breast cancer patients.
Arch Gynecol Obstet. 1990;247(4):203-9. doi: 10.1007/BF02389545.
6
Hormone receptors in breast cancer.乳腺癌中的激素受体
Br Med J. 1978 Jul 8;2(6130):77-8.
本文引用的文献
1
Characterization and assay of steroid hormone receptors and steroid-binding serum proteins by agargel electrophoresis at low temperature.
Hoppe Seylers Z Physiol Chem. 1972 Aug;353(8):1235-45. doi: 10.1515/bchm2.1972.353.2.1235.
Zotero 插件